Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-204815
Filing Date
2018-06-27
Accepted
2018-06-27 09:02:33
Documents
4
Effectiveness Date
2018-06-27

Document Format Files

Seq Description Document Type Size
1 S-8 d552911ds8.htm S-8 69480
2 EX-5.1 d552911dex51.htm EX-5.1 7101
3 EX-23.2 d552911dex232.htm EX-23.2 1531
4 GRAPHIC g552911g40s26.jpg GRAPHIC 2564
  Complete submission text file 0001193125-18-204815.txt   82841
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-225902 | Film No.: 18920611
SIC: 2834 Pharmaceutical Preparations